logo
TSE:4519 logo

Chugai Pharmaceutical Community

TSE:4519 Community
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 2 Fair Values set on narratives written by author
Create a narrative

Community Investing Ideas

4519 logo
Chugai Pharmaceutical
AN
AnalystConsensusTarget
Consensus Narrative from 15 Analysts

Hemlibra And Actemra Will Fuel Global Market Opportunities

Key Takeaways Strong overseas demand and product innovations are expected to drive significant revenue growth and enhance long-term revenue stability. Operational efficiencies and a reduced cost-to-sales ratio suggest potential for improved net margins and sustained profitability.
View narrative
JP¥8.13k
FV
10.0% undervalued intrinsic discount
2.96%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
11 days ago author updated this narrative